IL32 and metastatic malignant neoplasm in the lymph nodes: The overexpression of IL-32 increases the tumor size and lymph node metastasis in breast cancer, and IL-32 expression is also associated with tumor metastasis and cancer cell migration in gastric and lung cancers [40,41,42].